HCM
EVH icon

Highbridge Capital Management’s Evolent Health EVH Stock Holding History

Highbridge Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,739
Closed -$206K – 1334
2017
Q4 		$206K Sell
16,739
-3,859
-19% -$54.4K ﹤0.01% 1489
2017
Q3 		$366K Buy
+20,598
New +$424K 0.01% 1108
2017
Q1 		– Sell
-93,925
Closed -$1.39M – 1498
2016
Q4 		$1.39M Buy
+93,925
New +$1.85M 0.02% 464

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
FG
Formula Growth Montreal, Quebec, Canada $222M AUM 27.84% 1-Year Est. Return

Highbridge Capital Management's EVH Position: Q1 2018 in Review

Highbridge Capital Management sold out of Evolent Health (EVH) in Q1 2018, closing a stake of 16,739 shares — an estimated $206K sold.

Highbridge Capital Management first reported a position in EVH in Q4 2016 and held it in 3 quarters. The position peaked at $1.39M in Q4 2016. 152 funds tracked by Wall St. Rank hold EVH as of Q1 2018.

  • Highbridge Capital Management reported no remaining Evolent Health position as of Q1 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 16,739 Evolent Health shares in Q1 2018, an estimated $206K.
  • Highbridge Capital Management first reported a position in Evolent Health in Q4 2016 and held it in 3 quarters.
  • Highbridge Capital Management's Evolent Health position peaked at $1.39M in Q4 2016.
  • 152 funds tracked by Wall St. Rank held Evolent Health as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.